article

Drug Target Review – Issue #3 2016

Posted: 20 September 2016 | Drug Target Review | No comments yet

In Issue #3 2016: Flow Cytometry, Enzymes, Imaging, GPCRs, Hit-To-Lead, CNS, Companion Diagnostics, and much more…

DTR Issue 3 iPad

In Issue #3 2016 of Drug Target Review:

  • FOREWORD: Paying to be obvious – ingenuity and patent law
    Jacob Gifford Head, Thomas More Chambers
  • FLOW CYTOMETRY: Breaking bottlenecks in drug discovery and development
    Pushpanathan Muthuirulan, National Institutes of Health and Pooja Sharma, University of Maryland
  • ENZYMES: Switching on genes regulating oxysterol synthesis – a therapeutic option?
    Steve Meaney, Dublin Institute of Technology
  • IMAGING IN-DEPTH FOCUS
    With articles from Norman Peterson, MedImmune/AstraZeneca, and Janet Brownlees, Emilie Bureau, Jenny Cook and Debra Taylor, MRC Technology
  • GPCRs: High-throughput calcium flux assays – luminescent versus fluorescent readout
    Nicolas Houvenaghel, Jans Mia, Van der Schueren Jan and Christophe Thierry, Galapagos NV
  • HIT-TO-LEAD IN-DEPTH FOCUS
    With contributions from Douglas B. Kitchen and Mark Wolf, Albany Molecular Research, and Martina Fenske and Sheraz Gul, Fraunhofer IME
  • CNS: Fibromyalgia pathogenesis provides drug target clues
    Kim Lawson, Sheffield Hallam University
  • COMPANION DIAGNOSTICS
    Interview with Pierre Belichard, CEO of Enterome Biosciences

Issue #3 2016 is restricted to logged-in members. Login or subscribe free to read it.


Leave a Reply

Your email address will not be published. Required fields are marked *

Send this to a friend